Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

727
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
727
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

204
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
204
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Data-Driven Guideline Adherence in Data Representation and Compliance Measurement: Scoping Review.

Journal of medical Internet research·2026
Same author

C-CTX1 and 17-OH-C-CTX1 Accumulation in Muscle and Liver of Dusky Grouper (<i>Epinephelus marginatus</i>, Lowe 1834): A Unique Experimental Study Under Low-Level Exposure.

Toxins·2026
Same author

Evaluating the Utility of a Clinical Sepsis AI Tool in Emergency Waiting Rooms: A Preliminary Silent Trial.

Studies in health technology and informatics·2025
Same author

Opportunities and Challenges Associated with the Pilot Implementation of Clinical Decision Support Systems in a Rural Hospital: A Qualitative Study.

Applied clinical informatics·2025
Same author

Pathologists' integration of prior biopsies of women with germline PTEN mutations may expedite the identification of this rare cancer predisposition syndrome.

Pathology·2024
Same author

Clinical, histological and receptor profiles of invasive breast cancer and ductal carcinoma in situ in females with germline pathogenic variants in PTEN and implications for germline testing.

Pathology·2024

Related Experiment Video

Updated: Jul 5, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Equitable Machine Learning for Hypoglycaemia Risk Management.

Jhordany Rodriguez1, Daniel Padilla1, Lenert Bruce2

  • 1Alcidion, South Yarra, VIC, US.

Studies in Health Technology and Informatics
|January 25, 2024
PubMed
Summary

A new machine learning (ML) model accurately detects hospital patients at high risk for hypoglycemia. This tool aims to improve patient safety by enabling early intervention and reducing preventable errors.

Keywords:
AIMachine learningdiabetesemrequityfairnesshypoglycaemia

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

Related Experiment Videos

Last Updated: Jul 5, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.1K

Area of Science:

  • Clinical Informatics
  • Artificial Intelligence in Healthcare
  • Patient Safety

Background:

  • Hypoglycaemia poses a significant risk to hospitalized patients.
  • Current detection methods may be insufficient for timely intervention.
  • Machine learning offers potential for proactive risk identification.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting high-risk hypoglycaemia events in hospitalized patients.
  • To improve the early detection and management of hypoglycaemia.
  • To ensure equitable performance across different patient subgroups.

Main Methods:

  • Development of a machine learning model using data from an Australian regional health district.
  • Training the model on historical patient data to identify risk factors for hypoglycaemia.
  • Conducting subgroup analyses based on gender and Indigenous status to assess model fairness.

Main Results:

  • The machine learning model demonstrated strong predictive performance with an Area Under the Curve (AUC) of 0.837.
  • Subgroup analysis indicated that the model did not disadvantage specific population groups.
  • The model's reliance on objective data reduced bias associated with practice patterns.

Conclusions:

  • Machine learning models can effectively identify high-risk patient cohorts for hypoglycaemia.
  • Careful equity analysis is crucial for unbiased ML deployment in healthcare.
  • Automated detection and mitigation strategies hold promise for reducing preventable errors and improving patient safety.